Abstract Submission Deadline
November 24-25, 2023
London, UK
We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.
Jean Roch Alliez
CHP Clairval France
Felician Stancioiu
Bio-Forum Foundation Romania
Sinerik Ayrapetyan
UNESCO Chair in Life Sciences Yerevan Armenia
Catherine M Cahill
Massachusetts General Hospital and Harvard Medical School USA
Gabriele Saretzki
Newcastle University UK
Mark Liker
University of Southern California USA
ST. Sara Tapia
Academic University Santiago Chile Chile
Matthew O.B. Olaogun
University of Medical Sciences Niger
The unprecedented success of our previous conference, as well as the resounding and ginormous responses received, has paved the way for the Parkinson's 2023 Organizing Committee to host the "12th International Conference on Parkinson's and Movement Disorders," which will be held in London, UK, from 23-25, 2023.
Parkinson's 2023 is your best opportunity to attend the world's largest gathering of people to join, give lectures, share experiences, and network with present and future scientists to gain knowledge more about in the field of neurology, neuroscience, the central nervous system, neuropharmacology, and neurodegenerative diseases, and to make a significant impact.
A diverse group of experts in the fields of neuroscience, neurology, and neurosurgery could use this year's conference, which has the innovative theme "Scientific Methodologies and Current Therapeutic approaches for Parkinson's Disease and Movement Disorders".
The mission of the Parkinson's 2023 conference is to enhance Parkinson's disease treatments, expedite the interpretation of front-line disclosure at the clinical level, and advance global logical collaboration, discussion, and commerce.
This is a great opportunity for the delegates to interact with world-class experts, scientists, and researchers. The interested participants can confirm their participation by registering for the Parkinson's 2023 along with your colleagues. This Conference will provide an excellent forum for leading scientists, business leaders, and investors in this exciting field to exchange ideas and authoritative world views.
Once again, we are grateful for all of your excellent and innovative research works. The calculated and pertinent knowledge that is given will also foster expertly coordinated efforts to support logical scientific advancements. We promise you'd have a incredible involvement with Parkinson's 2023 and a love for the great city of London.
Come together and discover London!
Parkinson's 2023 happy to invite you all!!
We take great pride in our world-renowned global event and delighted to welcome all attendees to our "12th International Conference on Parkinson's and Movement Disorder" in London, UK on November 23-25, 2023. This conference will provide new ideas, convictions, strategies, and tactics in an environment where no other conference will provide an impressive roaster of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference, and we welcome you all to attend.
Parkinson's 2023 encourages participants from all top academic institutions and clinical research labs to share their research on all facets of this quickly expanding subject, meet with top researchers, and display the most recent methods. This conference will primarily concentrate on the most recent and exciting advancements in Parkinson's research, and it will increase the opportunity for experts from around the world to interact scientifically.
Parkinson's 2023 is an annual gathering of Neurologists, Neurosurgeons Psychiatrists, Research Scholars, to discuss the future of neurological disorders in terms of collaboration and organizational development.
Parkinson's 2023 Highlights:
Why to attend?
We strive to make the 12th International Conference on Parkinson's and Movement Disorders a great success, with support from the neuroscience panels and affiliations and high-caliber presentations from neurologists. This is your definitive great opportunity at Parkinson's conference, with people from all around the world focused on learning more about its advancements in neurology. This gathering will feature renowned speakers, the most cutting-edge techniques, and experts in neuroscience. The participants can find specialiszed speeches and workshops on the most recent developments in neuroscience and neurological disorders by
Benifits of attending the conference:
Target Audience
Opportunities for Conference Attendees
For Researchers & Faculty:
For Universities, Associations & Societies:
For Students & Research Scholars:
For Business Delegates:
For Companies:
A Golden opportunity for Sponsors, Exhibitors and Advertisers at this International Event:
Past Conference Report
The 11th International Conference on Parkinson's and Movement Disorders was conducted in Dubai, UAE from Dec 09-10, 2022 as Virtual event. The meeting was effectively organized at the conference venue with the assistance and participation of the Organizing Committee Members.
First of all, we will thank you for trusting us and engaging in Parkinsons 2022, an international forum for exploring various important facets of neurology and neuroscience. There are countless opportunities to expand our thanks to you for hosting an excellent Parkinsons 2022 virual meeting. We couldn't have achieved this without your continuing support and trust in our company, that, in order to achieve Parkinsons 2022, have made new heights in the area of Neurology and Neuroscience.
The meeting was distinguished by the presence of youthful and innovative scientists, industry participants and creative student groups from more than 20 nations, who have rendered this activity a success story.
The conference discussions are held through various scientific and plenary meetings. The meeting opened with an opening ceremony followed by a series of presentations by both Honourable Guests and representatives of the Keynote Panel. The adepts who executed the theme with their excellent talk and testimonials from keynote speakers and workshops;
Wagih El Masri | Keele University | UK
Agaezi Sonya | Sonya Health | USA
Peter Tass | Stanford University | USA
Sinerik Ayrapetyan| UNESCO Chair in Life Sciences Yerevan | Armenia
The event brought together different areas of Neurodegenerative Disorders with seminars and plenary talks by representatives from various universities and organisations.
Yekaterina Hovhannisyan| Heratsi N1 University Hospital Complex |Armenia
Marco Cassone | Hospital Major of Modica Nino Baglieri |Italy
Ana L. Albarracín | National University of Tucumán |Argentina
Yiping Chen | Shanxi Medical University |China
Jihoon Lee | Sanglah National Public Hospital|South Korea
Hamzeh Baharlouei| Aligarh Muslim University|Iran
Juan E Ferrario | Institute of Biosciences | Argentina
DMD Noura Hasan | Mansoura University | Egypt
Felician Stancioiu | Bio-Forum Foundation | Romania
Sinjan Choudhary | University of Mumbai | India
Mai M. Abdelmoaty | University of Nebraska Medical Center | USA
Felipe Gomes de Barros Pontes | Federal University of Sao Paulo | Brazil
Ni Made Dwita Pratiwi | Sanglah National Public Hospital | Indonesia
Ishrat Jahan | Aligarh Muslim University | India
As a follow-up to the Parkinsons 2022, we would like to cordially invite you to our forthcoming 12th International Conference on Parkinsons and Movement Disorders, scheduled to take place in London, UK, on December 09-10, 2023.
We look forward to seeing your friendly involvement and constructive participation and support to make this activity a success once again.
As the proud exhibitor, Head Instruments is honored to be part of this significant event dedicated to advancing Parkinson's research and treatment. Our team is excited to showcase our latest innovations in neurology diagnostics and therapeutic solutions. Join us at our booth to explore cutting-edge technologies that aim to make a positive impact on the lives of those affected by Parkinson's disease. Together, let's stride towards a brighter future for Parkinson's patients and their families.
About Head Instruments:
Head Instruments Ltd. develops and sells advanced medical technologies and products that improve quality of life and support medical professionals in their work treating and monitoring movement disorders triggered by Parkinson´s Disease. Head Instruments Movement Disorder Monitor is a wireless, real-time monitor that accurately analysis the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s Disease and other movement disorders and allows attending doctors and the patient to monitor the situation closely and compare the effectiveness of the selected treatment. It makes it significantly easier to adjust the treatment and patients reach the best balance of treatment faster. Embedded archiving properties keep the data comparable, which speeds up the treatment process and reduces unnecessary appointments. Head Instruments MDM saves time, cuts costs, increases effectiveness and ultimately significantly improves patients care.
Track-1: Parkinson’s disease
Parkinson’s disease is a dynamic issue that is brought about by degeneration of nerve cells in the part of the cerebrum called the substantia nigra, which controls development. These nerve cells pass on or become weakened, losing the capacity to create a significant chemical called dopamine. Studies have indicated that side effects of Parkinson’s create in patients with a 80 percent or more prominent loss of dopamine-delivering cells in the substantia nigra. Levodopa is frequently viewed as the highest quality level of Parkinson’s treatment. Levodopa works by intersection the blood-cerebrum barrier, the intricate meshwork of fine veins and cells that filter blood arriving the brain, where it is converted over into dopamine. Bromocriptine, pergolide, pramipexole and ropinirole are prescriptions that copy the job of chemical dispatchers in the cerebrum, making the neurons respond as they would to dopamine. With no known remedy for Parkinson’s disease, the goal of treatment through medication is to control symptoms of Parkinson’s .
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-2: Movement Disorder
Movement Disorder are a gathering of sensory system conditions that cause anomalous movement, for example fits, yanking or shaking, or, now and again, an absence of movement. Ataxia is a degenerative disorders in Parkinsons influencing the brain, brainstem or spinal cord. This can bring about awkwardness, mistake, flimsiness, lopsidedness, tremor or an absence of coordination while performing willful developments. Dystonia results from abnormal working of the basal ganglia, a profound part of the brain which helps control the coordination of movement. These districts of the cerebrum control the speed and ease of movement and avert undesirable movements. According to the Parkinsons Disease Foundation, Parkinsonian complexes affect nearly 1 million people in the United States and are the second most common neurodegenerative disease after Alzheimer’s disease.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-3: Epidemiology of Parkinsons
Parkinsons disease (PD) is one of the most recognized neurologic disorders, influencing roughly 1% of individuals older than 60 years and causing dynamic disability that can be eased back, yet not stopped, by treatment. The epidemiological highlights have been examined in depth, yet the techniques for Parkinsons used to move toward the issues have differed extraordinarily, and the outcomes spread a wide scope of components and are commonly uncertain. The rough predominance pace of Parkinsons Disease has been reported for to extend from 15 per 100,000 to 12,500 per 100,000, and the frequency of PD from 15 for every 100,000 to 328 per 100,000, with the disease being less normal in Asian countries. The health-related personal satisfaction of PD patients is connected not exclusively to their motor incapacity, but in addition to their non-motor symptoms of depression, sleeping Disorder, bladder, and sexual dysfunction.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-4: Neuromuscular Disorders
Neuromuscular disease is an expansive term that incorporates numerous ailments and disease that disable the working of the muscles. These may straightforwardly include the muscle legitimately or indirectly involve the nerves or the Neuromuscular junction. The indications of Neuromuscular illnesses may incorporate Numbness, Painful abnormal sensation, muscle weakness, muscle atrophy, muscle agony or jerking. Muscular dystrophy is a group of more than 30 conditions that lead to muscle shortcoming and degeneration. As the condition advances, it gets more diligently to move. At times, it can influence breathing and heart work, prompting perilous inconveniences.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson’s Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-5: Risk Factors of Parkinson’s Disease
The exact causes in Parkinson’s aren't completely comprehended, analysts have distinguished attributes that expansion an individual's risk of developing Parkinson’s, including sex, age, race, and hereditary factors. In any case, it is significant that by far most of instances of PD are viewed as idiopathic Parkinson’s malady. The investigation demonstrated that people with Parkinson’s disease were multiple times bound to have a background marked by melanoma. Moreover, individuals with melanoma had multiple times the risk of creating Parkinson’s.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-6: Mitochondrial Dysfunction
Mitochondrial dysfunction is the root cause of many diseases that are bewildering in their variety and complexity. They include rare genetic disorders in children, some forms of heart disease, and most likely many cases of Parkinson’s disease. Individuals with autism experience difficulty with communication. They experience trouble understanding what other individuals think and feel. This makes it difficult for them to convey what needs be, either with words or through motions, outward appearances, and contact.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery | International Journal of Neuroscience | Behavioural and Brain Sciences
Track-7: Neurosurgery
Neurosurgery is the careful specialization that treats maladies and disorders of the brain and spinal cord. Back pain can some of the time produce neurological manifestations, for example, deadness, muscle shortcoming, and loss of entrail and bladder control because of dysfunction at the nerve root. Stem cell-based medications are rising as the most encouraging methodology for the advancement of a valuable regenerative treatment that could be utilized in an enormous number of patients. In spite of the fact that progress in this field has been moderate, various energizing clinical preliminaries are currently not too far off, and there is a certifiable expectation that stem cells will enter the centre in the short-to-medium-term future.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson’s Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson’s and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-8: Neuroimaging
Neuroimaging is the order that manages the in vivo delineation of anatomy and capacity of the Central Nervous system (CNS) in wellbeing and disease. Diffusion tensor imaging (DTI) is a promising strategy for portraying microstructural changes or contrasts with neuropathology and treatment. The dissemination tensor might be utilized to describe the extent, anisotropy, and direction of the diffusion tensor.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-9: Free Radicals and Aging in Parkinsons
Free radical production and their focused on activity on biomolecules have roles in maturing and age-related disorders, for example, Parkinson’s disease (PD). There is an age-related increment in oxidative harm to the brain, and aging is viewed as a hazard factor for PD. The normal connection among aging and PD at the cellular level with unique reference to oxidative damage brought about by free radicals. Oxidative harm incorporates mitochondrial dysfunction, dopamine auto-oxidation, α-synuclein conglomeration, glial cell enactment, modifications in calcium flagging, and overabundance free iron.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson’s and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-10: Insights and therapeutics: Parkinsons disease
Mutations in the protein DJ-1 reason autosomal passive types of Parkinsons Disease (PD) and oxidized DJ-1 is found in the brain of idiopathic PD peoples. While a few capacities have been credited to DJ-1, its commitment to PD pathogenesis isn't yet clear. The pertinence of DJ-1 as a PD biomarker is additionally talked about, as are contemplates investigating DJ-1 as a potential remedial objective for PD and neurodegeneration. Monoamine oxidase inhibitors (MAOIs) were the principal sort of stimulant developed. They're successful, however they've by and large been supplanted by antidepressants that are more secure and cause less symptoms.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-11: Clinical Trials in Parkinsonism
Clinical Trials are structured by a severe convention or procedure, guaranteeing that new medicines are tried in a controlled manner to limit any hazard to members. The impact of the treatment is deliberately observed and, notwithstanding deciding their viability, information is gathered on security angles, for example, antagonistic responses and communication with different prescriptions. Here and there a preliminary will contemplate the impacts of utilizing a current treatment in various ways, for example, another plan of the medication.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-12: Parkinson’s disease Complication
Cognitive Problems may encounter psychological issues (dementia) and thinking troubles. These typically happen in the later phases of Parkinsons disease. Such cognitive issues aren't very receptive to medication. Depression and emotional changes may encounter melancholy, at times in the beginning periods. Getting treatment for depression can make it simpler to deal with different difficulties of Parkinsons Disease.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Track-13: Pathophysiology of Parkinsons
Physiologically, the side effects related with Parkinsons disease are the consequence of the loss of numerous neurotransmitters, most strikingly dopamine. The course of the disease is profoundly factor, with certain patients showing not very many side effects as they age and others whose side effects progress quickly. The motor signs of Parkinsons sickness are thought to bring about enormous part from decrease of dopamine in the basal ganglia. In the course of the most recent couple of years, a large number of the practical and anatomical outcomes of dopamine misfortune in these structures have been recognized, both in the basal ganglia and in related territories in thalamus and cortex.
Related Conferences:
Parkinson’s and Movement Disorder Conference | Parkinson’s , Huntington’s & Movement Disorder Conference | |Parkinson’s Congress| Parkinson’s disease and Movement Disorder Conference | Movement Disorder in Children and Young Adults Conference | Parkinson’s and Alzheimer’s Conference | Parkinson’s Meeting | Movement Disorder meeting | Parkinson’s Conference | Movement Disorder Conference
Related Association and Societies:
National Parkinson Foundation | European Parkinson’s Disease Association | American Parkinson Disease Association | UK Parkinson’s Action Network | American Academy of Neurology, Movement Disorder Society | European Neurological Society | Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW | Parkinson’s Unity Walk | Movement Disorder Society of Japan | Austrian Parkinson’s Disease Society | International Parkinson and Movement Disorder Society | Danish Movement Disorder Society.
Associated Journals:
Journal of npj Parkinson’s Disease | Journal of Brain and Neurology |Journal of Neuroscience |Journal of Neurology | Journal of Neuroscience Research | Journal of Brain Disorders and Neurosurgery |International Journal of Neuroscience | Behavioural and Brain Sciences
Parkinson's disease, which primarily affects adults and older people, is a degenerative nervous system ailment marked by tremor, muscle rigidity, and moderate, imprecise movement. It is associated with a lack of the neurotransmitter dopamine and basal ganglia brain degeneration.
According to neurological research studies to date, which demonstrated that dopamine, a neurotransmitter in the brain, gradually decreased its rate and that leads to Parkinson's disease, dopamine-producing cells known as dopaminergic neurons in the substantia nigra section of the brain, have died. The progressive neurological system disorder affects how people move, including how they talk, write, walk, and engage in other voluntary tasks. Parkinson's disease death rates have increased despite the use of numerous treatments for the condition.
Parkinson's disease is a degenerative mobility disability resulting from neurodegeneration. Globally, Parkinson's disease affects about 10 million individuals. Around 2.18 million cases were reported globally in 2012, and the US market had $1.15 billion in sales. The US Parkinson's disease market is anticipated to grow at a rate of 7.3 percent, from $1.1 billion in sales in 2012 to $2.3 billion in 2022. By 2022, the value of the treatment market is anticipated to have increased from $3.6 billion in 2024. By 2022, the US will have a 44 percent market share for Parkinson's clinical disease, up from 32 percent in 2012. Japan, Brazil, and Germany will follow with 13 percent, 11 percent, and 10 percent of the market share, respectively. In the US, 60,000 new cases of Parkinson's disease are diagnosed each year, affecting around 1 million people. In the UK, PD affects approximately 127,000 people. Males have a 50% higher risk than females, however 4–5% of patient cases—known as Parkinson's disease Young-onset—occur in patients under the age of 40.
According to Technavio's most recent industry analysis, the market for Parkinson's disease (PD) medications is anticipated to expand by USD 1.57 billion between 2019 and 2024 at a CAGR of 6%. During the projection period, Europe will account for 37% of market growth. The major markets in Europe for medications for Parkinson's disease (PD) are Germany, Italy, the UK, and Spain. This region's market will grow more quickly than the markets in Asia and North America combined. The Parkinson's disease (PD) medicine market will increase in Europe over the projection period due to the high prevalence of the condition and the simple accessibility of numerous authorised medications.
Major Associations around the globe:
Top universities globally working in the field of Parkinson Disease
Hospital Associated with Parkinson Disease:
Make a note of the following beneficial Parkinson’s 2023 deadlines.
Conference Dates: November 23-25, 2023
Early Bird Registration Deadline (Phase 1): 20 April 2023
Early Bird Registration Deadline (Phase 2): 10 May2023
Abstract Submission Deadline (Phase 2): 15 September 2023
Final Paper Submission Deadline: 28 September 2023
Abstract Acceptance/ Rejection: 24-48 hours
Group Registrations Waivers Available
Kindly contact Jenny Royce (Senior Program Manager) for further assistance via,
WhatsApp: +44 2080 400 181
Email: parkinsons@pulsusdiscussion.com
Best speaker will be selected by OCM for “Outstanding Research Award”
Benefits:
Advancing perfection and perceiving remarkable commitments made by the youthful researchers for their work done essentially during the span of study.
Two researchers will be chosen for the Awards.
Best Poster Award
3 Best posters will be awarded at the closing ceremony of the conference will be selected by OCM.
Benefits
Metrics
Pulsus Group, one of the best scientific conference planners in the world, has a unique voice in every field of business, technology, and research. A conference series success is directly influenced by how far it reaches an online community. Every international conference, whether it be for research, academia, or business, needs an online audience. Research personnel, Academicians, Research institutes, Industrialists and students from the field of Neurology are the key participants who show intense desire in attending the Parkinsons conference. Conferences based on Neuroscience and Neurology shows a significantly large number of unique visitors and page views which were proved to be a thriving success.
